Volume 90 Issue 43 | p. 23 | Concentrates
Issue Date: October 22, 2012

Eisai Focuses On Personalized Medicine

Department: Business
Keywords: personalized medicine, diagnostics, Japan, pharmaceutical, restructuring

Japan’s Eisai will dissolve a 10-year-old subsidiary as part of a strategy to increase its focus on personalized medicine. Tokyo-based Palma Bee’Z Research Institute, a diagnostics R&D unit of Eisai, will be absorbed into a restructured and refocused Eisai R&D organization. Set up in 2002, Palm Bee’Z focuses on diagnostics that apply gene signal amplification technology discovered in-house.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment